Current trends of surgical therapy of focal liver and pancreatic lesions

Czech version

Authors: Z. Šubrt ^1,2; A. Ferko ^1,2; F. Čečka ¹; B. Jon ¹
Authors‘ workplace: Chirurgická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Alexander Ferko, CSc. ¹; Katedra válečné chirurgie Fakulta vojenského zdravotnictví Univerzity obrany Brno, vedoucí doc. MUDr. Leo Klein, CSc. ²
Published in: Vnitř Lék 2011; 57(4): 356-363
Category: 12th national Symposium diabetes, "Diabetes and Gastroenterology", Hradec Kralove, 4 to 5 June 2010

Overview

Focal liver and pancreatic lesions represent important therapeutic problem in a relatively huge group of patients. Secondary liver tumors are the crucial factor affecting morbidity and mortality in patients with malignancies. Radical surgery is the only therapeutic option that gives the chance of long term survival. The authors present current trends in surgical therapy of liver and pancreatic tumors as a review article.

Key words:
liver – pancreas – tumor – liver resection – pancreatic resection – surgical therapy

Sources

1. Skalický T, Třeška V, Šnajdauf J. Chirurgie jater. Praha: Maxdorf 2005.

2. Are C, Gonen M, Zazzali K et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 2007; 246: 295–300.

3. Poston GS, Blumgart LH (eds). Surgical management of hepatobiliary and pancreatic disorders. London: Martin Dunitz 2003.

4. Aloia TA, Vauthey JN, Leyer EM et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006; 141: 460–467.

5. Válek V, Kala Z, Kiss I et al. Maligní ložiskové procesy jater. Diagnostika a léčba včetně minimálně invazivních metod. 1. vyd. Praha: Grada Publishing 2006.

6. Ehrmann J, Hůlek P et al. Hepatologie. Praha: Grada Publishing 2010.

7. Terblanche J. Surgery of liver tumors. HPB Surg 1989; 1: 173–184.

8. Tanabe KK. The past 60 years in liver surgery. Cancer 2008; 113 (Suppl 7): 1888–1896.

9. Kapp N, Curtis KM. Hormonal contraceptive use aminy women with liver tumors: a systematic review. Contraception 2009; 80: 387–390.

10. Buell JF, Tranchart H, Canon R et al. Management of benign hepatic tumors. Surg Clin North Am 2010; 90: 719–735.

11. Di Sandro S, Slim AO, Lauterio A et al. Liver adenomatosis: a rare indication for living donor liver transplantation. Transplant Proc 2009; 41: 1375–1377.

12. ÚZIS ČR. Novotvary 2004. Praha: ÚZIS ČR 2007.

13. Fraker DL, Soulen M. Regional therapy of hepatic metastase. Hematol Oncol Clin North Am 2002; 16: 947–967.

14. Manfredi S, Lepage C, Hatem C et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254–259.

15. Aloia TA, Zorzi D, Abdalla E et al. Two--surgeon technique for hepatic parenchymal transection of the non-cirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 2005; 242: 172–177.

16. Takayama T, Makuuchi M, Kubota K et al. Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg 2001; 136: 922–928.

17. Rau HG, Wichmann MW, Schinkel S et al. Wasserstrahldissektion bei Leberresektion: Ultraschallaspirator versus Jet-Cutter. Eine prospektiv randomisierte studie. Zentralbl Chir 2001; 126: 586–590.

18. Lupo L, Gallerani A, Panzera P et al. Randomized Clinical Trial of Radiofrequency-Assisted Versus Clamp-Crushing Liver Resection. Br J Surg 2007; 94: 287–291.

19. Castaldo ET, Earl TM, Chari RS et al. A Clinical Comparative Analysis of Crush/Clamp, Stapler, and Dissecting Sealer Hepatic Transection Methods. HPB 2008; 10: 321–326.

20. Lesurtel M, Selzner M, Petrowsky H et al. How Should Transection of the Liver Be Performed?: a Prospective Randomized Study in 100 Consecutive Patients: Comparing Four Different Transection Strategies. Ann Surg 2005; 242: 814–823.

21. Lee KF, Cheung YS, Chong CN et al. Laparoscopic versus open hepatectomy for liver tumours: a case control study. Hong Kong Med J 2007; 13: 442–448.

22. Gigot JF, Glineur D, Santiago Azagra J et al. Hepatobiliary and Pancreatic Section of the Royal Belgian Society of Surgery and the Belgian Group for Endoscopic Surgery. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 2002; 236: 90–97.

23. Mala T, Edwin B, Rosseland AR et al. Laparoscopic liver resection: experience of 53 procedures at a single center. J Hepatobiliary Pancreat Surg 2005; 12: 298–303.

24. Třeška V. Technika jaterních resekcí – současné možnosti. Rozhl Chir 2007; 86: 335–336.

25. Poultsides GA, Schulick RD, Pawlik TM. Hepatic resection for colorectal metastates: the impact of surgical margin status on outcome. HPB 2010; 12: 43–49.

26. Nuzzo G, Giuliante F, Ardito F et al. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 2008; 143: 384–393.

27. Sjövall A, Järv V, Blomqvis L et al. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol 2004; 30: 834–841.

28. Adam R. Developing strategies for liver metastases from colorectal cancer. Sem Oncol 2007; 34 (2 Suppl 1): 7–11.

29. Liu LX, Zhang WH, Juany HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003; 9: 193–200.

30. Jaeck D, Oussoulztzoglou E, Rosso E et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037–1051.

31. Berber E, Senagore A, Remzi F et al. Laparoscopic radiofrequency ablation of liver tumors combined with colorectal procedures. Surg Laparosc Endosc Percutan Tech 2004; 14: 186–190.

32. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6: 14–23.

33. Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1–8.

34. Mazzaferro V, Battiston C, Perrone S et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240: 900–909.

35. Pulvirenti A, Garbagnati F, Regalia E et al. Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation. Transplant Proc 2001; 33: 1516–1517.

36. McGahan JP. Radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2004; 198: 853–855.

37. Abdalla EK, Vaulthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818–827.

38. Bleicher RJ, Allegro DP, Nora DT et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10: 52–58.

39. Wood TF, Rose DM, Chung M et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7: 593–600.

40. Kala Z, Kiss I, Válek V et al. Nádory podjaterní oblasti. Praha: Grada Publishing 2010.

41. Čečka F, Jon B, Hatlová J et al. Renal cell carcinoma metastatic to the pankreas: a single center experience. Hepatogastroenterology 2009; 56: 1529–1532.

42. Joseph B, Morton J, Hernandez-Boussard MT et al. Relationship between hospital volume, system clinical resources, and mortality in pancreatic resection. J Am Coll Surg 2009; 208: 520–527.

43. Yekebas EF, Bogoevski D, Cataldegirmen G et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 2008; 247: 300–309.

44. Riall TS, Cameron JL, Lillemoe KD et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma – part 3: update on 5-year survival. J Gastrointest Surg 2005; 9: 191–1204.

45. Diener MK, Knaebel HP, Heukaufer C. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 2007; 245: 187–200.

46. Kleeff J, Diener MK, Z’graggen K et al. Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg 2007; 245: 573–582.

47. Andtbacka RH, Evans DB, Pisters PW. Surgical and endoscopic palliation for pancreatic cancer. Minerva Chir 2004; 59: 123–136.

48. Bradley EL 3rd, Bem J. Nerve blocks and neuroablative surgery for chronic pancreatitis. World J Surg 2003; 27: 1241–1248.

49. Smith AC, Dowsett JF, Russell RC et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344: 1655–1660.

50. Köninger J, Wente MN, Müller MW et al. Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg 2007; 392: 13–21.

51. Takaori K, Tanigawa N. Laparoscopic pancreatic resection: the past, present, and future. Surg Today 2007; 37: 535–545.